European Respiratory Review: 26 (145)

30 September 2017; volume 26, issue 145

Editorial

Open Access
Rare pulmonary diseases: a common fight
Sergio Harari, Marc Humbert

European Respiratory Review 26 (145) 170059; DOI: 10.1183/16000617.0059-2017 Published 6 September 2017
Open Access
Bronchoscopy and bleeding risk
Felix J.F. Herth

European Respiratory Review 26 (145) 170052; DOI: 10.1183/16000617.0052-2017 Published 19 July 2017
Open Access
The threat in chronic lung diseases: acute exacerbations
Michael Kreuter, Vincent Cottin

European Respiratory Review 26 (145) 170075; DOI: 10.1183/16000617.0075-2017 Published 27 September 2017
Open Access
Personalised medicine: are we ready?
Renaud Louis, Nicolas Roche

European Respiratory Review 26 (145) 170088; DOI: 10.1183/16000617.0088-2017 Published 27 September 2017

Frontiers in Clinical Practice

Open Access
How I manage pulmonary Langerhans cell histiocytosis
Gwenaël Lorillon, Abdellatif Tazi

European Respiratory Review 26 (145) 170070; DOI: 10.1183/16000617.0070-2017 Published 6 September 2017

Reviews

Open Access
Heritable pulmonary hypertension: from bench to bedside
Barbara Girerd, Jason Weatherald, David Montani, Marc Humbert

European Respiratory Review 26 (145) 170037; DOI: 10.1183/16000617.0037-2017 Published 6 September 2017
Open Access
Pulmonary hypertension in systemic sclerosis: different phenotypes
David Launay, Vincent Sobanski, Eric Hachulla, Marc Humbert

European Respiratory Review 26 (145) 170056; DOI: 10.1183/16000617.0056-2017 Published 27 September 2017
Open Access
Clinical care for primary ciliary dyskinesia: current challenges and future directions
Bruna Rubbo, Jane S. Lucas

European Respiratory Review 26 (145) 170023; DOI: 10.1183/16000617.0023-2017 Published 6 September 2017
Open Access
New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis
Olga Torre, Davide Elia, Antonella Caminati, Sergio Harari

European Respiratory Review 26 (145) 170042; DOI: 10.1183/16000617.0042-2017 Published 27 September 2017
Open Access
The lung in amyloidosis
Paolo Milani, Marco Basset, Francesca Russo, Andrea Foli, Giovanni Palladini, Giampaolo Merlini

European Respiratory Review 26 (145) 170046; DOI: 10.1183/16000617.0046-2017 Published 6 September 2017
Open Access
Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
Ganesh Raghu

European Respiratory Review 26 (145) 170071; DOI: 10.1183/16000617.0071-2017 Published 27 September 2017
Open Access
Severe idiopathic pulmonary fibrosis: what can be done?
Antonella Caminati, Roberto Cassandro, Olga Torre, Sergio Harari

European Respiratory Review 26 (145) 170047; DOI: 10.1183/16000617.0047-2017 Published 27 September 2017
Open Access
When to start and when to stop antifibrotic therapies
Sebastiano Emanuele Torrisi, Mauro Pavone, Ada Vancheri, Carlo Vancheri

European Respiratory Review 26 (145) 170053; DOI: 10.1183/16000617.0053-2017 Published 3 October 2017
Open Access
Management of antithrombotic agents in patients undergoing flexible bronchoscopy
Sami Abuqayyas, Shine Raju, John R. Bartholomew, Roulan Abu Hweij, Atul C. Mehta

European Respiratory Review 26 (145) 170001; DOI: 10.1183/16000617.0001-2017 Published 19 July 2017
Open Access
Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures
Vikas Pathak, J. Erin Allender, Mollie W. Grant

European Respiratory Review 26 (145) 170020; DOI: 10.1183/16000617.0020-2017 Published 19 July 2017
Open Access
Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities
Salvatore Corrao, Giuseppe Brunori, Umberto Lupo, Francesco Perticone

European Respiratory Review 26 (145) 160123; DOI: 10.1183/16000617.0123-2016 Published 9 August 2017
Open Access
Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device
Eleni Ischaki, Ioannis Pantazopoulos, Spyros Zakynthinos

European Respiratory Review 26 (145) 170028; DOI: 10.1183/16000617.0028-2017 Published 9 August 2017
Open Access
Systems medicine advances in interstitial lung disease
Flavia R. Greiffo, Oliver Eickelberg, Isis E. Fernandez

European Respiratory Review 26 (145) 170021; DOI: 10.1183/16000617.0021-2017 Published 27 September 2017

Series

Acute Exacerbations in Pulmonary Medicine
- Open Access
  Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis
  Yasuhiro Kondoh, Vincent Cottin, Kevin K. Brown
  
  European Respiratory Review 26 (145) 170050; DOI: 10.1183/16000617.0050-2017 Published 27 September 2017
Personalised Medicine in Respiratory Diseases
- Open Access
  Personalised medicine in asthma: time for action
  Kian Fan Chung
  
  European Respiratory Review 26 (145) 170064; DOI: 10.1183/16000617.0064-2017 Published 27 September 2017
Pathology for the Clinician
- Open Access
  The role of macrophages in interstitial lung diseases
  Giulio Rossi, Alberto Cavazza, Paolo Spagnolo, Salvatore Bellafiore, Elisabetta Kuhn, Pierpaolo Carassai, Laura Caramanico, Gloria Montanari, Gaia Cappiello, Alessandro Andreani, Francesca Bono, Nazarena Nannini
  
  European Respiratory Review 26 (145) 170009; DOI: 10.1183/16000617.0009-2017 Published 19 July 2017
- Open Access
  Differential diagnosis of granulomatous lung disease: clues and pitfalls
  Shinichiro Ohshimo, Josune Guzman, Ulrich Costabel, Francesco Bonella
  
  European Respiratory Review 26 (145) 170012; DOI: 10.1183/16000617.0012-2017 Published 9 August 2017
Exertional Dyspnoea
- Open Access
  Exertional dyspnoea in pulmonary arterial hypertension
  Daniel Dumitrescu, Olivier Sitbon, Jason Weatherald, Luke S. Howard
  
  European Respiratory Review 26 (145) 170039; DOI: 10.1183/16000617.0039-2017 Published 6 September 2017
Radiology
- Open Access
  Evaluating disease severity in idiopathic pulmonary fibrosis
  Hasti Robbie, Cécile Daccord, Felix Chua, Anand Devaraj
  
  European Respiratory Review 26 (145) 170051; DOI: 10.1183/16000617.0051-2017 Published 6 September 2017

Agora

Correspondence
- Open Access
  Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence
  Michele R. Schaeffer, Yannick Molgat-Seon, Christopher J. Ryerson, Jordan A. Guenette
  
  European Respiratory Review 26 (145) 170033; DOI: 10.1183/16000617.0033-2017 Published 9 August 2017
- Open Access
  Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence
  Emily C. Bell, Narelle S. Cox, Nicole Goh, Ian Glaspole, Glen P. Westall, Alice Watson, Anne E. Holland
  
  European Respiratory Review 26 (145) 170072; DOI: 10.1183/16000617.0072-2017 Published 9 August 2017

Main menu

User menu

Search

Table of Contents

Editorial

Frontiers in Clinical Practice

Reviews

Series

Acute Exacerbations in Pulmonary Medicine

Personalised Medicine in Respiratory Diseases

Pathology for the Clinician

Exertional Dyspnoea

Radiology

Agora

Correspondence

Search Within This Issue

Jump to

Contact us